The global ferric sulfate drug market size surpassed USD 1,058 billion in 2024 and is predicted to reach around USD 1,566 billion by 2034, registering a CAGR of 4% from 2024 to 2034.
The ferric sulfate market refers to the production, distribution, and application of these sulfates which is a family of inorganic compounds with the formula Fe2(SO4)3(H2O)n. It is a grayish-white powder or yellow lumpy crystals. These sulfates are medications used as coagulants and hemostatic agents. This is also used as a hemostatic agent in different medical practices. It is also used to treat iron deficiency anemia. There is a high demand for these sulfates including dyes, pigments, fertilizers, chemical synthesis, sewage treatment, and water treatment which is driving the growth of the ferric sulfate market.
However, the challenging factors of the market include increasing environmental concerns, increased production costs, changing raw material prices, increasing health concerns, and supply chain disruptions that can limit the growth of the market. The future scope of the market includes focusing on developing innovative solutions to meet customer needs, continuous investment in research and development, reducing its environmental footprints, providing sustainable solutions, and focusing on innovation and sustainability that will help the growth of the ferric sulfate market. Asia Pacific region dominates the growth of the market.
Published by Saurabh Bidwai
